NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Cancer Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Anticancer Gene



FHIT induced apoptosis of cancer cells is limited by substrate binding



April 22nd, 2003

Fhit-induced apoptosis of cancer cells is limited by substrate binding.

According to a study from the United States, "The FHIT gene is inactivated early in the development of many human tumors, and Fhit-deficient mice have increased cancer incidence. Viral reexpression of Fhit kills Fhit-deficient cells by induction of apoptosis.

"Fhit, a member of branch 2 of the histidine-triad superfamily of nucleoside monophosphate hydrolases and transferases, is a diadenosine polyphosphate hydrolase, the active-site histidine of which is not required for tumor suppression.

"To provide a rigorous test of the hypothesis that Fhit function...


Source: Cancer Weekly (2003-04-22)

NewsRx Passes
Advertisement
More Articles

------------------------
Security by Verisign PR Login